MRI delays troubling England as well as Canada

Dave Pearson | | Health Imaging | Policy & Regulations

Patient delays related to MRI exams seem to be contagious—and even capable of crossing the Atlantic.

Earlier this week came word of a problem with wait times to get scanned in Saskatchewa, Canada. Now we’re hearing about trouble getting results, and possibly scan appointments as well, from England.

“There should be a telephone helpline for patients to ring up to gauge some idea of when their results should be available,” Dr. Nainesh Chotai of Glenfield Hospital in Leicester, East Midlands, told the BBC.

Delays affected 1,300 MRI scan patients in Leicester, U.K., in October and, by the end of November, 738 patients had been waiting more than four weeks, according to the Beeb.

Read the article:

MRI scan delays causing East Midlands patients ‘distress’

Dave Pearson
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Related Content

University of Missouri Health Care's 7T scanner joins exclusive ACR accreditation club
Radiologist arrested for secretly recording female patient's breasts during imaging
Why cardiac CT adoption remains low among primary care providers
Injuries trigger recall related to tables used during image-guided procedures
New FDA-cleared algorithm could improve fetal anomaly detection on ultrasound
Center for Devices and Radiological Health hit with federal job cuts

Around the web

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

Cardiovascular Business
Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.